Metabolic & Incretin Pathway Research Peptides

This collection features peptides and analogs investigated in incretin receptor signaling (GLP-1R, GIP-R, and glucagon receptor pathways), AMPK pathway activation, lipolysis regulation, and metabolic phenotyping within preclinical endocrinology models. Scientists employ these compounds to study glucose homeostasis mechanisms, insulin secretion signaling, mitochondrial biogenesis, energy expenditure pathways, and metabolic adaptation in cell culture and rodent models. Available compounds include GLP-1 receptor agonists, GLP-2 analogs, dual and triple-agonist constructs, exercise-mimetic peptides, and AOD-9604—each examined for specific receptor interactions and enzymatic pathway activation. Research spans biochemical assays, tissue culture systems, metabolic phenotyping protocols, glucose tolerance studies, and whole-body energy metabolism measurements. Studies investigate insulin sensitivity, lipid metabolism pathways, mitochondrial dynamics and biogenesis, and metabolic gene expression profiles. Additional investigations examine adipose tissue browning, thermogenesis, and autophagy pathways. Glucose clamp studies, adipose tissue sampling, and hepatic glucose output measurement complete assessment. All products are research-use-only and are explicitly not intended for human consumption, weight management, or therapeutic medical application.

Popular research compounds in this category include GLP-3 (RTA), GLP-1 (SMA) and GLP-2 (TRZ). All are supplied for laboratory research use only.